Holman, Rury R.

Aetiology of type 2 diabetes in people with a 'normal’ body mass index: testing the personal fat threshold hypothesis

Taylor, R., Barnes, A. C., Hollingsworth, K. G., Irvine, K. M., Solovyova, A. S., Clark, L., Kelly, T., Martin-Ruiz, C., Romeres, D., Koulman, A., et al. (2023) · Clinical Science

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 71

Confirming the bidirectional nature of the association between severe hypoglycemic and cardiovascular events in type 2 diabetes: insights from EXSCEL

Standl, E., Stevens, S. R., Lokhnygina, Y., Bethel, M. A., Buse, J. B., Gustavson, S. M., Maggioni, A. P., Mentz, R. J., Hernandez, A. F., & Holman, R. R. (2020) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 65

THE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES

HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 64

Maintenance of Basal Plasma Glucose and Insulin Concentrations in Maturity-Onset Diabetes

Holman, R. R., & Turner, R. C. (1979) · Diabetes

Pancreatic function and diabetesDiabetes Management and Research

Cited by 62

Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with Type 2 diabetes

Bethel, M. A., Harrison, P., Sourij, H., Sun, Y., Tucker, L., Kennedy, I., White, S., Hill, L., Oulhaj, A., Coleman, R. L., et al. (2016) · Diabetic Medicine

Antiplatelet Therapy and Cardiovascular DiseasesPlatelet Disorders and Treatments

Cited by 61

Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial

Kraus, W. E., Yates, T., Tuomilehto, J., Sun, J.-L., Thomas, L., McMurray, J. J. V., Bethel, M. A., & Holman, R. R. (2018) · BMJ Open Diabetes Research & Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 59

A1C targets should be personalized to maximize benefits while limiting risks

Riddle, M. C., Gerstein, H. C., Holman, R. R., Inzucchi, S. E., Zinman, B., Zoungas, S., & Cefalu, W. T. (2018) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 54

Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR

Huffman, K. M., Sun, J.-L., Thomas, L., Bales, C. W., Califf, R. M., Yates, T., Davies, M. J., Holman, R. R., McMurray, J. J. V., Bethel, M. A., et al. (2014) · Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and Health

Cited by 45

Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

Bethel, M. A., Patel, R. A., Thompson, V. P., Merrill, P., Reed, S. D., Li, Y., Ahmadi, S., Katona, B. G., Gustavson, S. M., Ohman, P., et al. (2019) · Diabetes Care

Thyroid Cancer Diagnosis and TreatmentThyroid Disorders and Treatments

Cited by 43

Effect of once‐weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial

van der Aart‐van der Beek, A. B., Clegg, L. E., Penland, R. C., Boulton, D. W., Sjöström, C. D., Mentz, R. J., Holman, R. R., & Heerspink, H. J. L. (2020) · Diabetes, Obesity and Metabolism

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 37

Poor pregnancy outcome for women with Type 2 diabetes

Hadden, D. R., Cull, C. A., Croft, D. J., & Holman, R. R. (2003) · Diabetic Medicine

Gestational Diabetes Research and ManagementPregnancy and Medication Impact

Cited by 12

Updated risk factors should be used to predict development of diabetes

Bethel, M. A., Hyland, K. A., Chacra, A. R., Deedwania, P., Fulcher, G. R., Holman, R. R., Jenssen, T., Levitt, N. S., McMurray, J. J. V., Boutati, E., et al. (2017) · Journal of Diabetes and its Complications

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 12

Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial

de Barros e Silva, P. G. M., Califf, R. M., Sun, J.-L., McMurray, J. J. V., Holman, R., Haffner, S., Thomas, L., & Lopes, R. D. (2014) · International Journal of Cardiology

Chronic Obstructive Pulmonary Disease (COPD) ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 11

brief history of the UK Prospective Diabetes Study: RURY R HOLMAN, FOR THE UKPDS GROUP

Holman, R. (2022) · British Journal of Diabetes

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 10